News
New Study: SOYA (data)
Posted on September 8, 2017 by John Adams
A new study, The Study of Soy Isoflavones in Asthma (SOYA), has been posted to BioLINCC. Data from this study are available for requests.
New Study: GHCoE-New Delhi (data)
Posted on August 31, 2017 by John Adams
A new study, Global Health Centers of Excellence (GHCoE) New Delhi, has been posted to BioLINCC. Data from this study are available for requests.
New Study: GHCoE-Argentina (data)
Posted on August 31, 2017 by John Adams
A new study, Global Health Centers of Excellence (GHCoE) Argentina, has been posted to BioLINCC. Data from this study are available for requests.
COBLT Biospecimens Available
Posted on July 26, 2017 by John Adams
Biospecimens from the Cord Blood Transplantation Study (COBLT) are now available for request.
New Study: BRIDGE (data)
Posted on July 18, 2017 by John Adams
A new study, Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery (BRIDGE), has been posted to BioLINCC. Data from this study are available for requests.
New BioLINCC Manuscript
Posted on June 15, 2017 by Kirk Snyder
A new open-access paper about BioLINCC metrics and results is now available on PLOS ONE:
Giffen CA, Wagner EL, Adams JT, Hitchcock DM, Welniak LA, Brennan SP, Carroll LE. “Providing researchers with online access to NHLBI biospecimen collections: The results of the first six years of the NHLBI BioLINCC program”.
New Study: PROPPR (data)
Posted on June 1, 2017 by John Adams
A new study, Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR), has been posted to BioLINCC. Data from this study are available for requests.
New Study: BEST-COPD (data)
Posted on May 30, 2017 by John Adams
A new study, Broccoli Sprouts Extracts Trial (BEST-COPD), has been posted to BioLINCC. Data from this study are available for requests.
New Study: PLADO (data)
Posted on May 30, 2017 by John Adams
A new study, Determination of the Optimal Prophylactic Platelet Dose Strategy to Prevent Bleeding in Thrombocytopenic Patients (PLADO), has been posted to BioLINCC. Data from this study are available for requests.
New Study: BMT CTN-0603 (data)
Posted on May 3, 2017 by John Adams
A new study, Blood and Marrow Clinical Trials Network (BMT CTN) Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (0603), has been posted to BioLINCC. Data from this study are available for requests.
New Study: CPAP (data)
Posted on May 1, 2017 by John Adams
A new study, Effect of Positive Airway Pressure on Reducing Airway Reactivity in Patients With Asthma (CPAP), has been posted to BioLINCC. Data from this study are available for requests.
New Study: HFN-EXACT HF (data)
Posted on April 28, 2017 by John Adams
A new study, Heart Failure Network (HFN) Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT HF), has been posted to BioLINCC. Data from this study are available for requests.
New Study: HIT-RADIO (data)
Posted on April 27, 2017 by John Adams
A new study, Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study (HIT-RADIO), has been posted to BioLINCC. Data from this study are available for requests.
New Study: REDS II-Chagas (data)
Posted on April 26, 2017 by John Adams
A new study, Retrovirus Epidemiology Donor Study-II (REDS II) Natural History of Disease and Laboratory Findings in Trypanosoma Cruzi Antibody-Positive Brazilian Blood Donors (Chagas), has been posted to BioLINCC. Data from this study are available for requests.
New Study: SPIROMICS (data and specimens)
Posted on April 21, 2017 by John Adams
A new study, Subpopulations and Intermediate Markers in COPD Study (SPIROMICS), has been posted to BioLINCC. Data and specimens from this study are available for requests.
Data Update for CARDIA Study
Posted on April 18, 2017 by John Adams
Data have been updated for the CARDIA study (Coronary Artery Risk Development in Young Adults). Outcomes data with incident events through 2012 are now available.
New Study: CAPTION (data)
Posted on April 13, 2017 by John Adams
A new study, Collaboration Among Pharmacists and Physicians to Improve Outcomes Now (CAPTION), has been posted to BioLINCC. Data from this study are available for requests.
Notice of Change to Eligibility for RFA-HL-17-022
Posted on March 20, 2017 by Kirk Snyder
Notice of Change to Eligibility for RFA-HL-17-022 "Maximizing the Scientific Value of the NHLBI Biorepository: Scientific Opportunities for Exploratory Research (R21)".
The eligibility criteria for applications to RFA-HL-17-022 have been revised to allow foreign components, as defined in the NIH Grants Policy Statement.
The SPRINT-POP Challenge Winners Announced
Posted on March 15, 2017 by John Adams
The winners of the SPRINT-POP Challenge have been announced and are available for viewing at https://challenge.nejm.org/pages/winners
New Study: BMT CTN-0402 (data and specimens)
Posted on February 21, 2017 by John Adams
A new study, Blood and Marrow Clinical Trials Network (BMT CTN) A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus With Tacrolimus/Methotrexate as Graft-versus-Host Disease Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (0402), has been posted to BioLINCC. Data and specimens from this study are available for requests.
Funding Opportunity: NHLBI R21 PAR-17-004
Posted on February 16, 2017 by John Adams
This funding opportunity is to stimulate the use of existing human datasets for well-focused secondary analyses to investigate novel scientific ideas or new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the NHLBI mission. The next application due date is February 23, 2018.
For more information on PAR-17-004 please visit:
http://grants.nih.gov/grants/guide/pa-files/PAR-17-004.html
Funding Opportunity: NHLBI R21 RFA-HL-17-022
Posted on February 16, 2017 by John Adams
This funding opportunity is to support meritorious exploratory research relevant to the NHLBI mission using the biospecimen collections that are stored in the NHLBI Biorepository and that are available through BioLINCC. The next application due date is October 17, 2017.
For more information on RFA-HL-17-022 please visit:
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-17-022.html
and
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-17-494.html
New Study: THAPCA-OH (data)
Posted on February 10, 2017 by John Adams
A new study, Therapeutic Hypothermia After Pediatric Cardiac Arrest (Out of Hospital) (THAPCA-OH), has been posted to BioLINCC. Data from this study are available for requests.
Data Update for ARIC Study
Posted on February 6, 2017 by John Adams
Data have been updated for the Atherosclerosis Risk in Communities Study (ARIC). Now included are v1-v5 examination cycles, collated annual follow-up communication data for contact years 2-24, and follow-up for mortality, heart disease, and stroke events through 2011. Also included are data from two additional ancillary studies.
New Study: GenTAC (data and specimens)
Posted on January 19, 2017 by John Adams
A new study, National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC), has been posted to BioLINCC. Data and specimens from this study are available for requests.
New Study: BMT CTN-0401 (data)
Posted on December 8, 2016 by John Adams
A new study, Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Phase III Rituxan/BEAM vs. Bexxar/BEAM With Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Persistent or Relapsed Chemotherapy Sensitive Diffuse Large B-cell Non-Hodgkin's Lymphoma (0401), has been posted to BioLINCC. Data from this study are available for requests.
Data Update for MESA
Posted on November 18, 2016 by John Adams
Data have been updated for the Multi-Ethnic Study of Atherosclerosis (MESA) to include ancillary study #067 on MRI RV-function. Now available are data through exam 5, follow-up event data through year 10, and data from four ancillary studies.
FAQ for RFA-HL-17-022 now available
Posted on November 14, 2016 by Branson Beach
The RFA-HL-17-022 funding opportunity now has a FAQ available here: https://www.nhlbi.nih.gov/research/funding/faqs-rfahl022-maximizing-scientific-value-nhlbi-biorepository-scientific-opportunities-exploratory
New Study: BMT CTN-0302 (data)
Posted on November 4, 2016 by John Adams
A new study, Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Phase II Randomized Trial Evaluating Etanercept, Mycophenolate Mofetil, Denileukin Diftitox, and Pentostatin in Combination With Corticosteroids for Initial Systemic Treatment of Acute Graft-Versus-Host Disease (0302), has been posted to BioLINCC. Data from this study are available for requests.